National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)     
Last Modified: 05/22/2008
Health Professional Version
Regional Transitional Cell Cancer of the Renal Pelvis and Ureter

Current Clinical Trials

Treatment of extensive regional disease has thus far not had well-documented success by either radiation or systemic chemotherapy. Patients with extensive regional disease should be considered for clinical trials.

Current Clinical Trials

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with regional transitional cell cancer of the renal pelvis and ureter 1. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.

General information about clinical trials is also available from the NCI Web site 2.



Table of Links

1http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?diagnosis=40658&tt=1&a
mp;format=2&cn=1
2http://www.cancer.gov/clinicaltrials